ImmunoBiochem Corporation | Ontario at the Biotech Showcase 2026

sfo_preprocess_html() call_user_func_array() (Line: 261) Drupal\Core\Theme\ThemeManager->render() (Line: 490) Drupal\Core\Render\Renderer->doRender() (Line: 248) Drupal\Core\Render\Renderer->render() (Line: 158) Drupal\Core\Render\MainContent\HtmlRenderer->{closure:Drupal\Core\Render\MainContent\HtmlRenderer::renderResponse():153}() (Line: 637) Drupal\Core\Render\Renderer->executeInRenderContext() (Line: 153) Drupal\Core\Render\MainContent\HtmlRenderer->renderResponse() (Line: 90) Drupal\Core\EventSubscriber\MainContentViewSubscriber->onViewRenderArray() call_user_func() (Line: 111) Drupal\Component\EventDispatcher\ContainerAwareEventDispatcher->dispatch() (Line: 186) Symfony\Component\HttpKernel\HttpKernel->handleRaw() (Line: 76) Symfony\Component\HttpKernel\HttpKernel->handle() (Line: 53) Drupal\Core\StackMiddleware\Session->handle() (Line: 48) Drupal\Core\StackMiddleware\KernelPreHandle->handle() (Line: 28) Drupal\Core\StackMiddleware\ContentLength->handle() (Line: 32) Drupal\big_pipe\StackMiddleware\ContentLength->handle() (Line: 201) Drupal\page_cache\StackMiddleware\PageCache->fetch() (Line: 138) Drupal\page_cache\StackMiddleware\PageCache->lookup() (Line: 87) Drupal\page_cache\StackMiddleware\PageCache->handle() (Line: 48) Drupal\Core\StackMiddleware\ReverseProxyMiddleware->handle() (Line: 51) Drupal\Core\StackMiddleware\NegotiationMiddleware->handle() (Line: 36) Drupal\Core\StackMiddleware\AjaxPageState->handle() (Line: 51) Drupal\Core\StackMiddleware\StackedHttpKernel->handle() (Line: 741) Drupal\Core\DrupalKernel->handle() (Line: 19)

Profile

ImmunoBiochem is a pharma-partnered biotech developing novel bioconjugate therapeutics, such as ADCs and DACs, to address significant unmet need in various areas of immunology and oncology. ImmunoBiochem’s novel DACs for precision immunology utilize unique antibody targets for the delivery of potent protein degrader payloads that modulate validated immunological pathways in specific cell subtypes in the desirable context in various autoimmune disorders. This precision strategy increases efficacy allowing the full potential of modulating important immunological pathways to be realized, while avoiding the broad side-effects that limit the potential of currently approved biologics and small molecule therapeutics.

immunobiochem.com

Contact

Anton Neschadim, CEO and Director

Tel: +1 416-897-2789

Email: ceo@immunobiochem.com

Event details

Name: Ontario at the Biotech Showcase 2026

Date: January 12 - 14, 2026

Event contact

Patricia Cosgrove

Area Director

USA: Life Sciences

+1 647-293-6306

patricia.cosgrove@ontario.ca

Participants

21 in total

20/20 OptimEyes Technologies has developed a mucoadhesive drug delivery platform technology that allows for…
BioBox is a data integration and decision-intelligence platform for drug discovery. It helps biopharma bring…
Eurofins CDMO Alphora develops and…
Fibra turns everyday underwear into a real-time reproductive health platform — capturing critical biomarker data…
For over two decades, Toronto area-based GL CHEMTEC has been dedicated to delivering innovative…
HDAX Therapeutics, a biotechnology company pioneering a novel approach to target…
ImmunoBiochem is a pharma-partnered biotech developing novel bioconjugate therapeutics, such as…
Iseehear Inc. is a leading provider of comprehensive IT solutions for…
Kapoose Creek Bio is pioneering a new generation of therapeutics by fusing nature’s untapped chemistry with…
Lumerate is launching a new software brand called BioBackers - the intelligence platform for life science…
Medicenna is a clinical-stage immunotherapy company pioneering best- and/or first-in-class Superkines -…
Noa Therapeutics has developed a proprietary NRF2-…
Nucro-Technics is a GLP- and…
Paradox Immunotherapeutics is a biotech addressing the global burden of protein misfolding diseases—devastating…
Pattern Pharma’s patent-protected immunotherapeutic, PPI-100, mobilizes innate immunity by targeting…
ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. PQ…
QurCan Therapeutics is advancing the next wave of genetic medicines for CNS…
Rhythm Biotherapeutics develops first-in-class, heart-derived exosome therapeutics to prevent atrial fibrillation…
Spiderwort is a platform biomaterials company developing a suite of cellulose-based scaffolds for use in a number…
Tenomix’s mission is to develop novel technologies that target inefficiencies in the pathology workflow, optimize…
Transpharmation is a contract research organisation led by scientists. Recognised by drug developers worldwide…